Selecting an accurate point-of-care testing system: clinical and technical issues and implications in neonatal blood

Amy Sirkin1, Tina Jalloh, Luisa Lee

  • 1Saint Peter's University Hospital, New Brunswick, NJ, USA. asirkin@saintpetersuh.com

Insights

Rapid point-of-care glucose testing is vital for neonates to prevent neurological injury. Selecting the right system requires careful evaluation of accuracy, clinical benefits, and data management, balancing speed against lab testing delays.

Area of Science:

  • Neonatal medicine
  • Clinical chemistry
  • Medical device evaluation

Background:

  • Glucose abnormalities in neonates can lead to severe neurological damage.
  • Accurate and timely glucose monitoring is essential for neonatal care.
  • Point-of-care (POC) testing offers potential advantages over central laboratory analysis.

Purpose of the Study:

  • To highlight the critical need for rapid glucose testing in neonates.
  • To outline key considerations for selecting POC glucose testing systems.
  • To emphasize the importance of evaluating POC system accuracy and utility.

Main Methods:

  • This is a review and discussion of POC glucose testing systems.
  • Key performance metrics such as accuracy, precision, and versatility are discussed.
  • Potential sources of error and clinical utility in specific neonatal populations are considered.

Main Results:

  • POC glucose testing can provide rapid results, aiding prompt treatment decisions.
  • System selection involves balancing accuracy, clinical advantages, and data management.
  • The benefits of POC testing must be weighed against the time required for central lab analysis.

Conclusions:

  • Choosing a POC glucose monitoring system requires careful assessment of accuracy, precision, versatility, and infection control.
  • Post-selection studies are necessary to validate system performance and identify potential errors in the target neonatal population.
  • The decision to use POC testing should consider its advantages and limitations compared to traditional laboratory testing.
Abstract

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...